Implementation of a quality assurance program and quality control results of radiopharmaceuticals

In accordance with international guidelines and recommendations, the quality assurance (QA) program should cover all clinical aspects of nuclear medicine related to the smooth operation, including quality control (QC) of radiopharmaceuticals. In order to reduce risk of repeated studies, misinterpretation of the images and to protect patient from unnecessary radiation exposure due to poor quality radiopharmaceuticals, QC procedures should always be performed on a daily basis prior to radiopharmaceutical administration by appropriately trained personnel. The objective of this study was to evaluate quality control results of technetium (^99mTc) based radiopharmaceuticals and to determine the molybdenum (⁹⁹Mo) content in a ⁹⁹Mo/^99mTc generator eluate.